Free Trial

Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts

Avidity Biosciences logo
$13.24 -0.01 (-0.08%)
As of 10:47 AM Eastern

Avidity Biosciences Earnings Summary

Avidity Biosciences posted Q4 2025 earnings on February 23, 2026, reporting an EPS of -$1.59, which missed analysts' consensus estimates of -$1.24 by $0.35. Quarterly revenue was reported to be $0.86 million, below analyst estimates of $1.98 million. With a trailing EPS of $0.00, Avidity Biosciences' earnings are expected to decrease next year, from ($2.89) to ($3.34) per share.

Upcoming
Earnings Date
May. 14After Market ClosesEstimated
Consensus EPS
(Feb. 23)
-$1.24
Actual EPS
(Feb. 23)
-$1.59 Missed By -$0.35
Actual Revenue
(Feb. 23)
$0.86M

Q4 2025 Earnings Resources

RNA Upcoming Earnings

Avidity Biosciences' Q1 2026 earnings is estimated for Thursday, May 14, 2026, based on past reporting schedules

Get Avidity Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avidity Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avidity Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.49-$0.98-$1.24
Q2 20262-$1.50-$1.01-$1.26
Q3 20262-$1.49-$1.05-$1.27
Q4 20262-$1.46-$1.09-$1.28

Avidity Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/14/2026
(Estimated)
--------
2/23/2026Q4 2025-$1.24-$1.59 -$0.35-$1.59$1.98M$0.86M
11/10/2025Q3 2025-$1.05-$1.27 -$0.22-$1.27$1.80M$12.48M
5/8/2025Q1 2025-$0.88-$0.90 -$0.02-$0.90$2.63M$1.60M
2/27/2025Q4 2024-$0.76-$0.80 -$0.04-$0.80$1.74M$2.97M
11/7/2024--$0.79-$0.65+$0.14-$0.65$7.09M$2.34M
8/9/2024--$0.76-$0.65+$0.11-$0.65$7.09M$2.05M
5/15/2024--$0.81-$0.79+$0.02-$0.79$7.09M$3.54M

Data powered by Fiscal.ai.

Avidity Biosciences Earnings - Frequently Asked Questions

Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 14th, 2026 based off last year's report dates. Learn more on RNA's earnings history.

In the previous quarter, Avidity Biosciences (NASDAQ:RNA) missed the analysts' consensus estimate of ($1.24) by $0.35 with a reported earnings per share (EPS) of ($1.59). Learn more on analysts' earnings estimate vs. RNA's actual earnings.

Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $18.62 million.

Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$322.30 million. RNA has generated $0.00 earnings per share over the last four quarters.

Avidity Biosciences' earnings are expected to decrease from ($2.89) per share to ($3.34) per share in the next year.


This page (NASDAQ:RNA) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners